Identifying the single best pharmaceutical company for a long-term portfolio depends entirely on an investor's personal risk profile, asset allocation plan, and income versus growth goals. Major industry leaders span established multinational giants with deep global pipelines, as well as agile mid-cap domestic firms. To help tailor this perspective, what is your total investment horizon, and are you focusing on large-cap global diversified pharma or emerging domestic healthcare equities?